Product leaflet for the Tosoh HLC-723GX automated glycohemoglobin analyzer, an HPLC system for HbA1c testing with variant detection.
This leaflet describes the Tosoh HLC-723GX, an automated glycohemoglobin analyzer that uses high performance liquid chromatography (HPLC) to measure HbA1c. The method uses a resin-packed column in which hemoglobin fractions bind to the resin based on their charge, and buffers with specific ionic strengths separate the hemoglobin fractions. The analyzer is NGSP and IFCC certified and provides HbA1c results with variant detection.
The document lists the instrument's key benefits, including precision (CV of less than 1%), speed (results in 2.2 minutes and up to 10 samples in 26.4 minutes), automated features such as cap piercing and automated maintenance, a touch screen interface, and compact dimensions. It also includes ordering information for the analyzer, TSKgel GX column, elution buffers, hemolysis and wash solution, and HbA1c calibrator and control sets. The leaflet notes that the product is not FDA cleared and is available for sale only outside the U.S.
| Coefficient of variation (CV) | Less than 1% |
|---|---|
| Result time | 2.2 minutes |
| Throughput | Up to 10 samples in 26.4 minutes |
| Dimensions (W x D x H) | 14.6 x 20.7" x 18.9" |
| Weight | 55.1 lbs |
| Certification | NGSP and IFCC certified |
According to the leaflet, HbA1c results are unaffected in the presence of the most common hemoglobin variants, HbF, or hemoglobin derivatives such as labile and carbamylated hemoglobin.
No, the leaflet states the product is not FDA cleared and is available for sale only outside the U.S.
It uses a resin-packed HPLC column where hemoglobin fractions bind to the resin based on their charge, and buffers with specific ionic strengths are passed through the column to separate the fractions.
Yes, it includes automated daily maintenance routines to minimize downtime, along with automated features such as cap piercing and positive sample identification.